PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
9th Closed Expert Meeting of the PCSK9 Education and Research Forum

Lipoprotein(a) back on the agenda


Is lipoprotein(a) an independent risk factor in PCSK9 inhibitor outcomes studies?

Lead ODYSSEY Outcomes Investigator Professor Gregory Schwartz (University of Colorado, Aurora, USA) discusses the latest data

Listen to the presentation here »


Dr Erin Bohula (Brigham and Women’s Hospital and Harvard Medical School, Boston, USA) discusses data from the FOURIER trial

Listen to the presentation here »


What’s new about lipoprotein(a) genetics and cardiovascular risk?

Professor Anne Tybjaerg-Hansen (University of Copenhagen, Denmark) discusses the data

Listen to the presentation here »

Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Our popular therapeutic guide

Read online & download second edition now »

Register now at www.pcsk9forum.org to receive the updated third edition coming soon.
New eBook
Questions & Answers

Why are new treatments needed?

Read the full answer and other questions on the PCSK9 Forum »
Educational Partners
and Supporters
Amgen The Medicines Company Sanofi
Copyright PCSK9 Forum 2018. Please click here to unsubscribe from future mailings.